Literature DB >> 21710214

Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Anandi N Sheth1, Pragna Patel, Philip J Peters.   

Abstract

Influenza is a common respiratory disease in adults, including those infected with HIV. In the spring of 2009, a pandemic influenza A (H1N1) virus (pH1N1) emerged. In this article, we review the existing literature regarding pH1N1 virus infection in HIV-infected adults, which suggests that susceptibility to pH1N1 virus infection and severity of influenza illness are likely not increased in HIV-infected adults without advanced immunosuppression or comorbid conditions. The risk of influenza-related complications, however, may be increased in those with advanced immunosuppression or high-risk comorbid conditions. Prevention and treatment of high-risk comorbid conditions and annual influenza vaccination should continue to be part of HIV clinical care to help prevent influenza illness and complications. Additional information about pH1N1 vaccine immunogenicity and efficacy in HIV-infected patients would be useful to guide strategies to prevent influenza virus infection in this population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710214     DOI: 10.1007/s11904-011-0086-4

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  79 in total

1.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

2.  Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

Authors:  C L Celum; S P Buchbinder; D Donnell; J M Douglas ; K Mayer; B Koblin; M Marmor; S Bozeman; R M Grant; J Flores; H W Sheppard
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

3.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users.

Authors:  A Amendola; A Boschini; D Colzani; G Anselmi; A Oltolina; R Zucconi; M Begnini; S Besana; E Tanzi; A R Zanetti
Journal:  J Med Virol       Date:  2001-12       Impact factor: 2.327

5.  Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

Authors:  J C King; J Treanor; P E Fast; M Wolff; L Yan; D Iacuzio; B Readmond; D O'Brien; K Mallon; W E Highsmith; J S Lambert; R B Belshe
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Influenza A H1N1 in HIV-infected adults.

Authors:  E Martínez; M A Marcos; I Hoyo-Ulloa; A Antón; M Sánchez; A Vilella; M Larrousse; I Pérez; A Moreno; A Trilla; T Pumarola; J M Gatell
Journal:  HIV Med       Date:  2011-01-24       Impact factor: 3.180

7.  Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals.

Authors:  Jen Kok; Katherine Tudo; Christopher C Blyth; Hong Foo; Linda Hueston; Dominic E Dwyer
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

8.  Pandemic influenza A (H1N1) in HIV-1-infected patients.

Authors:  Carlos M Perez; Maria I Dominguez; Maria E Ceballos; Cristina Moreno; Jaime A Labarca; Ricardo Rabagliati; Patricia Vasquez; Martin Lasso; Michel Serri
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

9.  Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Authors:  Gwendolyn L Gilbert; Michelle A Cretikos; Linda Hueston; George Doukas; Brian O'Toole; Dominic E Dwyer
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

View more
  20 in total

1.  Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Authors:  Chiara Agrati; Cristiana Gioia; Concetta Castilletti; Daniele Lapa; Giulia Berno; Vincenzo Puro; Fabrizio Carletti; Eleonora Cimini; Carla Nisii; Flora Castellino; Federico Martini; Maria R Capobianchi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-08       Impact factor: 2.205

Review 2.  B cell function and influenza vaccine responses in healthy aging and disease.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Curr Opin Immunol       Date:  2014-06-14       Impact factor: 7.486

3.  Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.

Authors:  Mark J Abzug; Sharon A Nachman; Petronella Muresan; Edward Handelsman; D Heather Watts; Terence Fenton; Barbara Heckman; Elizabeth Petzold; Adriana Weinberg; Myron J Levin
Journal:  Clin Infect Dis       Date:  2013-02-01       Impact factor: 9.079

4.  Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013.

Authors:  Cheryl Cohen; Jocelyn Moyes; Stefano Tempia; Michelle Groome; Sibongile Walaza; Marthi Pretorius; Halima Dawood; Meera Chhagan; Summaya Haffejee; Ebrahim Variava; Kathleen Kahn; Anne von Gottberg; Nicole Wolter; Adam L Cohen; Babatyi Malope-Kgokong; Marietjie Venter; Shabir A Madhi
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

5.  Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 - a global mortality impact modeling study.

Authors:  Kathleen F Morales; John Paget; Peter Spreeuwenberg
Journal:  BMC Infect Dis       Date:  2017-09-25       Impact factor: 3.090

6.  Impact of Human Immunodeficiency Virus on the Burden and Severity of Influenza Illness in Malawian Adults: A Prospective Cohort and Parallel Case-Control Study.

Authors:  Antonia Ho; Stephen J Aston; Hannah Jary; Tamara Mitchell; Maaike Alaerts; Mavis Menyere; Jane Mallewa; Mulinda Nyirenda; Dean Everett; Robert S Heyderman; Neil French
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

7.  Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.

Authors:  Anita Parmigiani; Maria L Alcaide; Ricardo Freguja; Suresh Pallikkuth; Daniela Frasca; Margaret A Fischl; Savita Pahwa
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

8.  Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies.

Authors:  Ruth Lynfield; Richard Davey; Dominic E Dwyer; Marcelo H Losso; Deborah Wentworth; Alessandro Cozzi-Lepri; Kathy Herman-Lamin; Grazyna Cholewinska; Daniel David; Stefan Kuetter; Zelalem Ternesgen; Timothy M Uyeki; H Clifford Lane; Jens Lundgren; James D Neaton
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

9.  Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review.

Authors:  T J Cooper; B L Woodward; S Alom; A Harky
Journal:  HIV Med       Date:  2020-07-15       Impact factor: 3.094

Review 10.  Back to the Future: Lessons Learned From the 1918 Influenza Pandemic.

Authors:  Kirsty R Short; Katherine Kedzierska; Carolien E van de Sandt
Journal:  Front Cell Infect Microbiol       Date:  2018-10-08       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.